Seed Innovations Limited CEO Presenting at Proactive One2One Investor Forum

TIDMSEED

Seed Innovations Limited

22 January 2024

22 January 2024

SEED Innovations Limited

("SEED" or the "Company")

CEO Presenting at Proactive One2One Investor Forum

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, is pleased to announce that it will be participating in the Proactive One2One Investor Forum at the Chesterfield Mayfair Hotel in London from 6 pm on Thursday 25 January 2024.

The in-person event will allow interested investors to learn more about the Company's investment opportunity, strategy, and market drivers.

The agenda includes a presentation by Ed McDermott, CEO of Seed Innovations, to be followed by a short Q&A session.

The event will also be available to view afterwards on Proactive's YouTube channel and the Company's social media: https://twitter.com/SEEDInnov

For further details and to register your attendance, please click the following link: https://www.proactiveinvestors.co.uk/register/event_details/437

-Ends-

   For further information on the Company please visit:   www.seedinnovations.co   or contact: 
 
 Ed McDermott      SEED Innovations         E: [e-mail] 
  Lance de          Ltd 
  Jersey 
 James Biddle      Beaumont Cornish         T: (0)20 7628 3396 
  Roland Cornish    Limited, 
                    Nomad 
                  -----------------------  ------------------------------- 
 Isabella          Shard Capital Partners   T: (0)20 7186 9927 
  Pierre            LLP 
  Damon Heath       Broker 
                  -----------------------  ------------------------------- 
 Ana Ribeiro       St Brides Partners       E: [e-mail] 
  Isabelle          Ltd, 
  Morris            Financial PR 
                  -----------------------  ------------------------------- 
 

Notes

Seed Innovations Ltd

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRABTMTTMTMTMLI

(END) Dow Jones Newswires

January 22, 2024 02:00 ET (07:00 GMT)